2025 ICD-10-CM Diagnosis Code C88.31

Immunoproliferative small intestinal disease, in remission

ICD-10-CM Code:
C88.31
ICD-10 Code for:
Immunoproliferative small intestinal disease, in remission
Is Billable?
Yes - Valid for Submission
Code Navigator:

C88.31 is a billable diagnosis code used to specify a medical diagnosis of immunoproliferative small intestinal disease, in remission. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2024 through September 30, 2025.

Code Classification

  • Neoplasms
    (C00–D49)
    • Malignant neoplasms of lymphoid, hematopoietic and related tissue
      (C81-C96)
      • Malignant immunoproliferative diseases and certain other B-cell lymphomas
        (C88)

Clinical Information

  • Immunoproliferative Small Intestinal Disease

    a condition that is caused by hyperplasia of lymphocytes in the small intestine (intestine, small) and the mesenteric lymph nodes. these lymphocytes produce an anomalous alpha heavy chain protein. generally, these ipsid patients have either concurrent lymphoma or develop lymphoma within a few years. the disease was first described in the mediterranean region and is characterized by malabsorption; weight loss; diarrhea; and steatorrhea.

New 2025 ICD-10-CM Code

C88.31 is new to ICD-10-CM code set for the FY 2025, effective October 1, 2024. The National Center for Health Statistics (NCHS) has published an update to the ICD-10-CM diagnosis codes which became effective October 1, 2024. This is a new and revised code for the FY 2025 (October 1, 2024 - September 30, 2025).

Replacement Code

C8831 replaces the following previously assigned ICD-10-CM code(s):

  • Z85.79 - Prsnl hx of malig neoplm of lymphoid, hematpoetc & rel tiss

Code History